Biogen's Alzheimer drug Aduhelm proves drug prices are a lie — Quartz
When Biogen cut the price of its Alzheimer's drug in half, it exposed the arbitrary nature of drug pricing.
Source: qz.com
Stay updated with breaking news from Aduhelm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
When Biogen cut the price of its Alzheimer's drug in half, it exposed the arbitrary nature of drug pricing.
Biogen expects “minimal” revenue this year from its Alzheimer’s treatment initially...
Biogen expects “minimal” sales this year from its Alzheimer’s treatment initially...
Biogen expects “minimal” sales this year from its Alzheimer’s treatment initially...
Biogen expects “minimal” sales this year from its Alzheimer’s treatment initially...